{
    "nctId": "NCT05099978",
    "briefTitle": "Asian Multicenter Prospective Study of ctDNA Sequencing",
    "officialTitle": "Asian Multicenter Prospective Study of Circulating Tumor DNA Sequencing: A-TRAIN",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Cervical Cancer, Ovarian Clear Cell Carcinoma, Nasopharyngeal Carcinoma, Ovarian Cancer, Endometrial Cancer, Triple Negative Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 506,
    "primaryOutcomeMeasure": "Percentage of patients with one or more genetic abnormalities among all examination cases",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age of 18 years or older at registration.\n2. Diagnosis of cancer which is targeted by each cohort.\n3. Metastatic and/or recurrent disease.\n\nExclusion Criteria:\n\n1. Any other malignancy within 3 years prior to registration, except for adequately treated basal cell or squamous cell skin cancer, or carcinoma in situ of the esophagus, stomach, colon, or cervix.\n2. Ongoing chemotherapy. (Chemotherapy-na\u00efve patients or awaiting initiation of the next line of chemotherapy are eligible. There is no limit on the number of prior chemotherapies or on the time from completion of chemotherapy to registration).\n3. Ongoing radiation therapy. (There are no limits on the time from completion of radiation therapy to registration).",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}